💡AI Researchers Take Up Smoking to Bet on Machine God
AI Researchers Smoking to Bet on Machine God
TL;DR
AI researchers are taking up smoking as a show of faith in AI's ability to cure them. This behavior is seen as a social delusion, hindering real discussions about AI's impact. Effective altruism, a long-term approach to benefiting humans, is the driving philosophy behind this trend.
AI researchers are starting to smoke to signal their faith in AI's potential to cure any health issues that arise from smoking. This behavior is considered a mass psychosis and social delusion, distracting from meaningful discussions about AI's current capabilities. Effective altruism, a philosophy prioritizing long-term benefits for humanity, is the rationale behind this trend. AI researchers believe that the technology will eventually cure them of smoking-related illnesses, despite the lack of evidence that AI can develop new drugs quickly enough to help them. The timeline for developing new cancer drugs remains several years, making this a risky bet.
Key Points
AI researchers are taking up smoking as a show of faith in AI's future capabilities, despite the lack of evidence for immediate benefits.
Effective altruism, a philosophy prioritizing long-term benefits for humanity, is the driving force behind this trend among AI researchers.
Developing and introducing a new cancer drug into health systems can take several years, making the researchers' bet on AI's immediate healing abilities risky.
The year 2025 was predicted to be when humans would start popping AI-designed pills, but this hasn't happened yet, highlighting the overblown hype around AI's drug discovery capabilities.
AI's ability to discover drugs and medical treatments has been hyped, but there's no real indication that AI is going to kill us all or cure smoking-related illnesses in the near future.
Why It Matters
AI researchers taking up smoking as a bet on AI's future healing abilities is a social delusion driven by effective altruism. This trend distracts from meaningful discussions about AI's current limitations in drug discovery and development. The timeline for developing new cancer drugs remains several years, making this a risky bet for researchers who believe in AI's immediate benefits.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.